Amgen shared a post on X:
“Results from Amgen’s Phase 2 obesity study being presented during an expert-led symposium at the American Diabetes Association 85th Scientific Sessions.
The data evaluated MariTide in people living with obesity, with and without Type 2 diabetes.
Proceed to the video attached to the post.
More posts featuring AMGEN.